CBLL — Ceribell, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1861107 ·
Last close
$23.69
Market Cap
$909.18M
52W High
$25.63
52W Low
$10.85
ADV30
358,433
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 28,097,000 | 25,938,000 | -19,981,000 | -19,268,000 | 166,348,000 | 32,663,000 | 38,035,000 |
| Mar 2026 | 26,494,000 | 23,122,000 | -20,745,000 | -19,737,000 | 178,078,000 | 45,252,000 | 37,265,000 |
| Dec 2025 | 24,784,000 | 21,643,000 | -14,596,000 | -13,527,000 | 195,803,000 | 40,476,000 | 40,467,000 |
| Sep 2025 | 22,589,000 | 19,942,000 | -14,647,000 | -13,465,000 | 199,525,000 | 23,739,000 | 35,444,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-48,702,000
Investing CF
$-66,087,000
Financing CF
$6,681,000
CapEx
$-1,653,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.63
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-240,093,000
Inventory
$6,902,000
Receivables
$15,712,000
ST Investments
$95,932,000
EBIT TTM
$-58,519,000
Pretax Income TTM
$-60,372,000
Interest Exp TTM
$1,853,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$101,964,000
EBITDA
$-68,803,000
Free Cash Flow
$-33,047,376
Enterprise Value
$799,522,496
Total Cash
$129,261,000
Total Debt
$21,909,000
Shares Out
38,378,101
Trailing EPS
$-1.76
Book Value
$3.36
ROE
-43.9%
ROA
-23.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 89,063,000 | -58,402,000 | -53,412,000 | 195,803,000 | 40,467,000 | 155,336,000 | -40,808,000 |
| Dec 2024 | 65,444,000 | -39,709,000 | -40,455,000 | 225,412,000 | 34,247,000 | 191,165,000 | -35,043,000 |
| Dec 2023 | 45,225,000 | -30,041,000 | -29,464,000 | 58,922,000 | 171,174,000 | -112,252,000 | -29,159,000 |
| Dec 2022 | 25,922,000 | -36,021,000 | -37,164,000 | 86,458,000 | 172,856,000 | -86,398,000 | -32,002,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.61
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $23.69 · call volume: 15 · put volume: 4Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | $905.44M | $27.07 | — |
| BVS | Bioventus Inc. | $943.29M | $13.81 | — |
| BBNX | Beta Bionics, Inc. | $967.73M | $21.51 | — |
| PRCT | PROCEPT BioRobotics Corp | $979.00M | $17.20 | — |
| SIBN | SI-BONE, Inc. | $833.18M | $18.59 | — |
News headlines (Yahoo Finance, 1h cache)
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
2026-08-12 15:04 · Yahoo
CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...
2026-08-11 05:02 · Yahoo
CeriBell (CBLL) Q2 2026 Earnings Call Transcript
2026-08-11 01:43 · Yahoo
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
2026-08-10 23:00 · Yahoo
CeriBell Q2 Earnings Call Highlights
2026-08-10 22:04 · Yahoo
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates
2026-08-10 21:55 · Yahoo
CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System
2026-08-03 12:45 · Yahoo
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
2026-07-29 11:00 · Yahoo
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
2026-07-20 20:05 · Yahoo
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
2026-06-08 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.